
SMS Pharmaceuticals Ltd. (SMSPHARMA) Share Price Near 52-Week High as Stock Trades at Rs 486.30
Updated: 5 Oct 2026 • 9:57 am
Posted by:

SMS Pharmaceuticals Share Price is trading at Rs 486.30, up 3.12% from the previous close, and remains close to its 52-week high. The company’s market capitalisation stands at Rs 4,416.63 crore, placing SMS Pharmaceuticals Ltd. (SMSPHARMA) in focus in today’s stock market update. SMS Pharmaceuticals Share Price Today reflects a move that is measurable from the latest market data, while SMS Pharmaceuticals Stock News is being watched for its near one-year high setup. The latest Univest figures confirm the price event, but they do not establish a company-specific catalyst. For readers tracking SMS Pharmaceuticals Share Price Live, the key context is the day’s price range, valuation profile and how the stock compares with listed pharmaceutical peers.
As of 05 October 2026 at 9:52 AM IST, SMS Pharmaceuticals Share Price was Rs 486.30 after opening at Rs 478.35 and moving between Rs 472.65 and Rs 487.90 during the day. The stock was above the previous close of Rs 471.60 by Rs 14.70, and the near-52-week-high event keeps SMS Pharmaceuticals Share Price Today on the radar for Stock Market Today and Share Market Today searches. Univest data shows the latest move, but no company-specific reason is identified in the figures. For investors following SMS Pharmaceuticals Stock Analysis, the important question is not only the price action but also whether the valuation and financial ratios align with the current Share Price Update.
SMS Pharmaceuticals Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 486.3 |
| Previous Close | Rs 471.6 |
| Today's Move | +Rs 14.7 (+3.12%) |
| Open | Rs 478.35 |
| High | Rs 487.9 |
| Low | Rs 472.65 |
| Market Capitalisation | Rs 4,416.63 crore |
SMS Pharmaceuticals Ltd. (SMSPHARMA) traded at Rs 486.3 versus the previous close of Rs 471.6, a rise of 3.12%. The stock opened at Rs 478.35, reached a high of Rs 487.9 and touched a low of Rs 472.65.
SMS Pharmaceuticals Share Price Today shows a rise of Rs 14.70 from the previous close of Rs 471.60, which is a 3.12% move. The stock traded as low as Rs 472.65 and touched Rs 487.90, leaving it very near its yearly high zone. With the current print at Rs 486.30, SMS Pharmaceuticals Share Price remains within sight of the 52 Week High and is therefore appearing in 52 Week High Stocks searches.
The day’s opening price of Rs 478.35 placed the stock above the previous close, and the subsequent range kept SMS Pharmaceuticals Share Price Live within a relatively tight band for the morning session. For a reader checking SMS Pharmaceuticals Share Price Today, the verified facts show a firm intraday position without any unsupported explanation. Univest data confirms the move, while SMS Pharmaceuticals Stock News remains centred on the near-high price event rather than a stated trigger. That makes SMS Pharmaceuticals Share Price relevant for Stock Updates and Market Movers scans.
Because the stock is trading close to its 52-week high, SMS Pharmaceuticals Share Price is drawing attention as a price-led story rather than a headline-driven one. The next section looks at the company’s financial context, which is useful for SMS Pharmaceuticals Stock Analysis and SMS Pharmaceuticals Fundamental Analysis.
SMS Pharmaceuticals Ltd. (SMSPHARMA) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 4,416.63 crore |
| P/E Ratio | 43.13x |
| P/B Ratio | 5.48x |
| ROE | 12.49% |
| ROCE | 13.32% |
| EPS | Rs 10.93 |
| Book Value Per Share | Rs 86.06 |
| Dividend Yield | 0.08% |
SMS Pharmaceuticals Ltd. (SMSPHARMA) fundamental metrics show P/E 43.13x, P/B 5.48x, ROE 12.49%, ROCE 13.32%. These figures provide context only and are not a buy or sell signal.
SMS Pharmaceuticals Ltd. has a market capitalisation of Rs 4416.63 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 43.13x, P/B at 5.48x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 12.49% and ROCE of 13.32%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 10.93, book value per share of Rs 86.06, dividend yield of 0.08%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 27.52x, median ROE of 11.43%, median ROCE of 13.1%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 43.13x |
| Benchmark Median P/E | 27.52x |
| Benchmark Average P/E | 40.3x |
| Benchmark P/E Range | 0x to 685.2x |
| Company P/B Ratio | 5.48x |
| Benchmark Median P/B | 2.74x |
| Company ROE | 12.49% |
| Benchmark Median ROE | 11.43% |
| Company ROCE | 13.32% |
| Benchmark Median ROCE | 13.1% |
| Company Market Capitalisation | Rs 4,416.63 crore |
| Benchmark Median Market Cap | Rs 695.84 crore |
SMS Pharmaceuticals Ltd. (SMSPHARMA) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
SMS Pharmaceuticals Ltd. (SMSPHARMA) has a P/E ratio of 43.13x, which is above the benchmark median of 27.52x, a difference of +56.72%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
SMS Pharmaceuticals Ltd. (SMSPHARMA) has a ROE of 12.49%, which is above the benchmark median of 11.43%, a difference of +9.27%. SMS Pharmaceuticals Ltd. (SMSPHARMA) has a ROCE of 13.32%, which is above the benchmark median of 13.1%, a difference of +1.68%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Gufic Biosciences Ltd. | GUFICBIO | 4,193.81 | 57.09 | 6.1 | 10.14 | 12.56 |
| RPG Life Sciences Ltd. | RPGLIFE | 4,857.1 | 42.17 | 7.64 | 20.28 | 26.99 |
| Gujarat Themis Biosyn Ltd. | GUJTHEM | 4,976.35 | 102.21 | 4.74 | 17.41 | 18.16 |
| Aarti Drugs Ltd. | AARTIDRUGS | 3,852.05 | 20.15 | 2.41 | 13.36 | 12.04 |
| Unichem Laboratories Ltd. | UNICHEMLAB | 3,770.23 | 12.37 | 1.37 | 9.81 | 10.68 |
SMS Pharmaceuticals Ltd. (SMSPHARMA) has a P/E ratio of 43.13x compared with the displayed peer median of 42.17x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 12.49% compares with a peer median of 13.36% across the companies shown in the table. ROCE stood at 13.32% versus the displayed peer median of 12.56%, providing a capital-efficiency comparison. SMS Pharmaceuticals Ltd. (SMSPHARMA) has a market capitalisation of Rs 4,416.63 crore. Among the 5 peers shown, 2 have a larger market capitalisation.
Why Investors Are Watching SMS Pharmaceuticals
- SMS Pharmaceuticals Share Price is Rs 486.30, up 3.12% from the previous close of Rs 471.60.
- The stock is trading near its 52-week high and has moved within a day range of Rs 472.65 to Rs 487.90.
- Market capitalisation stands at Rs 4,416.63 crore, which is above the same-industry median market cap of Rs 695.84 crore.
- P/E is 43.13 and P/B is 5.48, both above the same-industry medians of 27.52 and 2.74.
- ROE is 12.49% and ROCE is 13.32%, both close to or above the benchmark medians in the same industry.
About SMS Pharmaceuticals
SMS Pharmaceuticals Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The company is tracked on NSE and BSE under SMSPHARMA. In the latest figures, SMS Pharmaceuticals Share Price is linked with market capitalisation of Rs 4,416.63 crore, EPS of 10.93 and book value per share of Rs 86.06. For SMS Pharmaceuticals Stock News readers, the business profile is useful mainly as a context layer around the current Share Price Today and the company’s valuation profile.
SMS Pharmaceuticals Share Price also draws interest because the latest revenue and profit numbers are visible in the company financials record. Univest users following SMS Pharmaceuticals Share Price Update can use the company page for a compact view of the stock, market cap and financial ratios in one place.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Registration Number INH000013776), a subsidiary of Univest Communication Technologies Private Limited.
Frequently Asked Questions
Why is SMS Pharmaceuticals Share Price in the news today?
Ans. SMS Pharmaceuticals Share Price is in focus because it is trading near its 52-week high and is up 3.12% at Rs 486.30. The latest figures show a measured price event, not a stated company-specific trigger.
What is SMS Pharmaceuticals Share Price Today?
Ans. SMS Pharmaceuticals Share Price Today is Rs 486.30. It is above the previous close of Rs 471.60 and has moved within a day range of Rs 472.65 to Rs 487.90.
How much did SMS Pharmaceuticals Share Price move today?
Ans. SMS Pharmaceuticals Share Price moved up by Rs 14.70, which equals 3.12%. That rise is visible from the latest price, previous close and intraday range figures. The intraday range extended from Rs 472.65 to Rs 487.9.
Is SMS Pharmaceuticals Share Price near its 52-week high?
Ans. Yes. SMS Pharmaceuticals Share Price is trading close to its 52-week high area. The latest market data places it at Rs 486.30, with a day high of Rs 487.90.
What is the market capitalisation of SMS Pharmaceuticals?
Ans. SMS Pharmaceuticals has a market capitalisation of Rs 4,416.63 crore. That figure is far above the same-industry median market cap of Rs 695.84 crore in the benchmark set.
How does SMS Pharmaceuticals compare on valuation?
Ans. SMS Pharmaceuticals Share Price corresponds to a P/E of 43.13 and a P/B of 5.48. Both are above the same-industry medians of 27.52 and 2.74, respectively. The peer average P/E is 40.3x.
What do the profitability ratios show for SMS Pharmaceuticals?
Ans. SMS Pharmaceuticals reports ROE of 12.49% and ROCE of 13.32%. Both are close to or above the same-industry medians, which helps frame the current SMS Pharmaceuticals Share Price.
How can investors track SMS Pharmaceuticals Share Price on Univest?
Ans. Investors can track SMS Pharmaceuticals Share Price on Univest for live price updates, company financials, valuation ratios, 52-week levels and market context. It is a useful page for regular stock monitoring.
Track SMS Pharmaceuticals Share Price on Univest
Use SMS Pharmaceuticals Ltd. (SMSPHARMA) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.
Readers can track SMS Pharmaceuticals Share Price on Univest for live price updates, market capitalisation, valuation ratios, company financials, 52-week levels and sector context. Univest also helps users follow SMS Pharmaceuticals Share Price Today alongside SMS Pharmaceuticals Stock News, SMS Pharmaceuticals Latest News and SMS Pharmaceuticals Share Price Live in one place.
For those scanning SMS Pharmaceuticals Fundamental Analysis or comparing SMS Pharmaceuticals Share Price with peers, Univest keeps the latest ratios, benchmarks and market context easy to review. That makes SMS Pharmaceuticals Share Price useful to monitor as part of a broader stock analysis routine.
Recent Articles

Gokaldas Exports Shares in Focus: Gokaldas Exports Q2 Results, the 5% Move in Five Days, the Exchange Filings and What Is Unverified
10 November 2026

FPI Inflows Hit Rs 53,739 Crore in November 2026 as FPIs Return to Indian Stocks: Reasons, Data Gaps and the Risks of a Reversal
10 November 2026

US Stocks Inflows of $2.1 Trillion: What the Wall Street Fund-Flow Figure Measures, What It Does Not, and Why the Numbers Differ by Source
10 November 2026

NSE New Headquarters Design Unveiled: The Plot, the Architect and What the NSE BKC Move Means for the Exchange and Investors
10 November 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Gokaldas Exports Shares in Focus: Gokaldas Exports Q2 Results, the 5% Move in Five Days, the Exchange Filings and What Is Unverified
FPI Inflows Hit Rs 53,739 Crore in November 2026 as FPIs Return to Indian Stocks: Reasons, Data Gaps and the Risks of a Reversal
US Stocks Inflows of $2.1 Trillion: What the Wall Street Fund-Flow Figure Measures, What It Does Not, and Why the Numbers Differ by Source
NSE New Headquarters Design Unveiled: The Plot, the Architect and What the NSE BKC Move Means for the Exchange and Investors
MRF Dividend 2026: India's Most Expensive Stock Declares a Rs 3 Payout, and What It Means for the MRF Share Price and Shareholders

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





